Clinical trial
Lung Cancer With Copanlisib and Durvalumab
NCT04895579
Study timeline
Study start (actual)2021-05-12Date precision: day
Registry last updated2025-11-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
DurvalumabDRUG · verified · RxNorm: durvalumab
CopanlisibDRUG · verified · RxNorm: copanlisib
Sponsors & collaborators
Zhonglin Haolead sponsor
Bayercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04895579 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.